High Tech Industry Veteran Will Focus on Broader Product Distribution, Revenue Growth and Profitability
SAN FRANCISCO, March 31 /PRNewswire/ -- DecisionView, Inc., the leading provider of Clinical Optimization Solutions for the Life Sciences industry, today announced that its Board of Directors has appointed James P. Scullion to the role of Chairman, President and CEO of DecisionView, effective immediately. Most recently, he held the role of Chairman for DecisionView. Scullion succeeds Steve Andrade as the Company's President and Chief Executive Officer.
"I'm very pleased that Jim has agreed to join DecisionView as its new CEO," said Chris Hollenbeck, a DecisionView Board Member. "We believe the market for clinical optimization solutions is poised for significant growth. Jim has over two decades of experience leading high tech companies, and his expertise will greatly benefit DecisionView as the company looks to extend its leadership position as a comprehensive provider of business performance optimization applications."
Mr. Scullion brings more than 20 years of experience as a "C" level executive in the high technology industry to his new position. Most recently, he served as Chairman and CEO of Tumbleweed Communications from January 2006 to September 2008. Under Mr. Scullion's leadership, Tumbleweed was successfully transformed from an email security centric company to a leading provider of secure content delivery solutions to Global 1000 and midmarket enterprises doubling its customer base from 1,700 to 3,500 customers. Tumbleweed was acquired by Sopra Group in September 2008. From January 2004 to January 2006, he was CEO of ComnetiX, Inc., a leading provider of criminal intelligence systems. During Mr. Scullion's tenure at ComnetiX, revenues grew threefold and he led the company's successful IPO on the Toronto Stock Exchange. From 1990 to 2002, he held senior management positions including President and COO with Identix Incorporated, a publicly traded biometric technology company. While at Identix, Scullion led the company's growth in annual revenues from $1 million to more than $80 million.
"DecisionView is the technology leader in the clinical recruitment optimization market," said Scullion. "I am excited to be joining a company that is well positioned to capitalize on a fast growing, high demand market. I believe my leadership and operational experience will further strengthen the already outstanding DecisionView team, and will help accelerate our company's growth as we expand and enrich our optimization solutions for the Life Sciences industry."
Steve Andrade will be leaving the company to pursue other interests and will also be stepping down from his position as a member of the DecisionView board of directors.
About DecisionView, Inc.
DecisionView develops innovative software solutions that optimize the clinical performance of life sciences organizations around the world. By uniquely converging predictive analytics, simulation, visualization and data aggregation capabilities into functionally rich and easy to use applications, the company's solutions deliver proven business value in faster cycle times, reducing clinical costs and improving clinical productivity. To learn more, visit www.decisionview.com.
CONTACT: Denise Welch of Dotted Line Communications, +1-781-849-2022,
Denise@dottedlinecomm.com, for DecisionView, Inc.
Web site: http://www.decisionview.com/